No photo available
Details - Information last confirmed on November 20, 2020
(Looking for partial equity sell off; Min 25% and/or full exit at right valuation).
The company is a US based licensed wholesaler / distributor and exporter of prescription pharmaceutical products. The company highly specializes in supplying much needed Branded prescription products to other product development companies, Clinical Research Organizations and other manufacturers for research purposes. Company's major customers are top pharmaceutical manufacturers in India & China. Company also has domestic State licenses in more 15 States and additional states can easily be acquired. Company has great relations with several vendors who help supply products as needed. Company also has ways and processes to obtain some specialty products directly from brand manufacturers. Company also has an office overseas with 5-7 account reps.
Adjusted EBITDA: $4.24MM
(after adding back two partner's salaries and withdrawals equaling close to $1.5MM combined)
Company, on an average maintains $5MM - $7MM in inventory, $6MM - $8MM in AR and $1.5MM - $2.8MM in AP and approx $1.5MM Cash in bank.
Company has yet to capitalize and expand into domestic North America market. Catering to local sales to CROs and other product development company can easily add another $20MM - $30MM with healthy margins. Company is in planning to hire a local Business Development person to oversee this market.
Company's owners have significant equity tied up in business and looking for partial or full exit at the right valuation.
Expected asking $18MM - $20MM which includes $5MM - $7MM in inventory, $8MM in AR, $3.9MM in AP and $1MM - $1.2MM Cash in bank.
Owners will need to see proof of funds before engaging in conversation with any potential parties.
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.